We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Fourteen Year Study Concludes: Anthocyanins Lower Hypertension Risk

By LabMedica International staff writers
Posted on 27 Jan 2011
Anthocyanins, obtained primarily from blueberries and strawberries, reduce the risk of developing hypertension and join the list of flavonoids present in tea, fruit juice, red wine, and dark chocolate as food products that protect against cardiovascular disease.

Investigators at the University of East Anglia (Norwich, United Kingdom) and the Harvard School of Public Health (Boston, MA, USA) followed the eating habits of more than 134,000 women and 47,000 men to examine the relationship between flavonoids and development of hypertension. More...
The subjects, none of whom suffered from hypertension at the beginning of the study, were monitored for 14 years. During this period, they completed health questionnaires every two years, and their dietary intake was assessed every four years.

Results published in the November 24, 2010, online edition of the American Journal of Clinical Nutrition revealed that 29,018 women and 5629 men developed hypertension over the 14-year study period. Evaluation of their dietary questionnaires showed that tea was the main contributor of flavonoids, with apples, orange juice, blueberries, red wine, and strawberries also providing important amounts. Further analysis revealed that subjects consuming the highest amounts of anthocyanins (found mainly in blueberries and strawberries) were 8% less likely to be diagnosed with hypertension than those consuming the lowest amounts. Blueberries were the most potent source of anthocyanins, and those eating at least one serving of blueberries per week were 10% less likely to become hypertensive than those eating no blueberries.

"Our findings are exciting and suggest that an achievable dietary intake of anthocyanins may contribute to the prevention of hypertension,” said first author Dr. Aedin Cassidy, professor of nutrition at the University of East Anglia. "Anthocyanins are readily incorporated into the diet as they are present in many commonly consumed foods. Blueberries were the richest source in this particular study as they are frequently consumed in the United States. Other rich sources of anthocyanins in the United Kingdom include blackcurrants, blood oranges, aubergines [eggplant], and raspberries.”

Related Links:
University of East Anglia
Harvard School of Public Health


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
New
Gold Member
Platelet Function Analyzer
PL-12
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers developed three mathematical biomarkers from routine PSA blood tests that may help predict early prostate cancer treatment outcomes and personalize adaptive therapy (Image Credit: Adobe Stock)

Mathematical Biomarkers Use Routine Blood Tests to Guide Adaptive Prostate Cancer Therapy

Personalizing systemic therapy for prostate cancer remains challenging because tumors can evolve under treatment pressure, driving resistance and early relapse. Continuous high-dose regimens may initially... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.